General Gastro News Articles
Gastro
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Gastro
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Gastro
        Basic Science/Genetics
        Biliary System/Pancreas
        Colorectal Cancer/Polyps
        Economics of Medicine
        Endoscopy
        Esophagus
        GERD/Stomach
        GI Bleeding
        GI Infectious Disease
        GI Motility
        GI Oncology
        Hepatology
        Inflammatory Bowel Dz
        Obesity
        Parenteral/Ent Nutrition
        Peds Gastroenterology
        Pharmacology/kinetics
        Popular Press
        Radiology/Diagnostics
        Small/Large Intestine
        Transplant
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
esophageal  esophageal
probiotics  probiotics
bile duct  bile duct
hepatotoxicity  hepatotoxicity
dyspepsia  dyspepsia
colonoscopy  colonoscopy
helicobacter  helicobacter
hemochromatosis  hemochromatosis
colitis  colitis
resection  resection
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
Effectiveness of stent placement for palliative treatment in malignant colorectal obstruction and predictive factors for stent occlusion
Suh JP et al. - In a trial to evaluate the effectiveness of stent placement for palliative treatment and to identify predictive factors associated with stent occlusion, it was reported that uncovered self-expandable metallic stent (SEMS) placement is an effective palliative treatment for malignant colorectal obstruction. The degree of stent expansion 48 hr after stent placement is significantly associated with maintenance of stent patency and is a predictive factor for stent occlusion.

Methods
  • A retrospective analysis was performed in 55 pts who had undergone placement of an uncovered SEMS for palliative treatment of malignant colorectal obstruction with metastatic or locally advanced cancer that was surgically unresectable.
  • Technical and clinical outcomes of stent placement, complications related to the procedure, stent patency rate, and predictive factors associated with stent occlusion were analyzed.

Results
  • Causes of colorectal obstruction before stent placement were primary colorectal cancer in 42 pts and noncolorectal extrinsic cancer in 13 pts.
  • Initial technical success rate was 98.2%, and clinical success rate was 94.4%.
  • Complications occurred in 17 pts (30.9%), including stent occlusion (n=8), migration (n=6), bowel perforation (n=1), stent distortion (n=1), and fistula formation (n=1).
  • Mean and median stent patency periods were 184 days and 141 days, respectively.
  • Degree of expansion 48 hr after stent placement was significantly better in the nonocclusion group than in the stent occlusion group.
  • Insufficient stent expansion (<70%) 48 hr after stent placement was significantly associated with an increase in stent occlusion during the follow-up period.
[more...]
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Gastroenterology Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.